The paediatric population includes a category of patients with dynamic changes (due to the continuous body growth). Therefore their treatment requires individualized drug dosing (according to body weight) and the availability of different dosage forms for the same treatment due to different ability of paediatric patients to handle liquid (too much for older children and adolescents) or solid dosage forms (so hard and too big to be swallowed by infants and small children). Mostly, liquid and solid dosage forms are necessary to satisfy the needs for all age-range of paediatrics. However, on the market, there is a lack of appropriate dosage forms for paediatric patients
The total number of paediatric formulations available only account for a small proportion of the ful...
The development of pediatric-specific dose forms is particularly difficult due to a variety of facto...
Selecting the appropriate formulation and solubility-enabling technology for poorly water soluble dr...
The paediatric population includes a category of patients with dynamic changes (due to the continuou...
Developing suitable paediatric formulations and ensuring access to them by the greatest number of th...
Developing suitable paediatric formulations and ensuring access to them by the greatest number of th...
The paediatric drug development is associated with numerous challenges. As a result, only a fraction...
For over 15 years, US and EU regulations ensure that medicines developed for children are explicitly...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
The pharmaceutical industry supplies oral solid dosage forms which are generally inadequate for pedi...
<small>The use of unlicensed and off-label medicines in children is widespread and has raised an in...
Introduction The World Health Organisation (WHO) recommends that children be treated with oral solid...
Pediatric oral drug dosage forms can be scientifically challenging to develop, and the choice of whi...
Due to the lack of age-appropriate formulations for children, healthcare professionals and caregiver...
The total number of paediatric formulations available only account for a small proportion of the ful...
The development of pediatric-specific dose forms is particularly difficult due to a variety of facto...
Selecting the appropriate formulation and solubility-enabling technology for poorly water soluble dr...
The paediatric population includes a category of patients with dynamic changes (due to the continuou...
Developing suitable paediatric formulations and ensuring access to them by the greatest number of th...
Developing suitable paediatric formulations and ensuring access to them by the greatest number of th...
The paediatric drug development is associated with numerous challenges. As a result, only a fraction...
For over 15 years, US and EU regulations ensure that medicines developed for children are explicitly...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
The pharmaceutical industry supplies oral solid dosage forms which are generally inadequate for pedi...
<small>The use of unlicensed and off-label medicines in children is widespread and has raised an in...
Introduction The World Health Organisation (WHO) recommends that children be treated with oral solid...
Pediatric oral drug dosage forms can be scientifically challenging to develop, and the choice of whi...
Due to the lack of age-appropriate formulations for children, healthcare professionals and caregiver...
The total number of paediatric formulations available only account for a small proportion of the ful...
The development of pediatric-specific dose forms is particularly difficult due to a variety of facto...
Selecting the appropriate formulation and solubility-enabling technology for poorly water soluble dr...